Showing results (391-400 of 454) with videos related to

Sort By:
Pageof 46
Cell Death & Disease|December 13, 2023
Chlorpromazine affects glioblastoma bioenergetics by interfering with pyruvate kinase M2Claudia Abbruzzese, Silvia Matteoni, Paola Matarrese, et al.
Frontiers in Oncology|October 3, 2022
Effectiveness of a phone-based nurse monitoring assessment and intervention for chemotherapy-related toxicity: A randomized multicenter trialAndrea Antonuzzo, Carla Ida Ripamonti, Fausto Roila, et al.
The Oncologist|January 26, 2026
Clinical characteristics and Drug-Drug interactions in HER2+ breast cancer treated with T-DXd: Real-World data from the DE-REAL studySimona Pisegna, Simone Scagnoli, Gabriella Gentile, et al.
International Journal of Molecular Sciences|July 29, 2025
HER2-Driven Breast Cancer: Role of the Chaperonin HSP90 in Modulating Response to Trastuzumab-Based Therapeutic CombinationsItalia Falcone, Elena Giontella, Stefano Giuliani, et al.
Journal of Inorganic Biochemistry|February 19, 2017
The dissociation of the Hsp60/pro-Caspase-3 complex by bis(pyridyl)oxadiazole copper complex (CubipyOXA) leads to cell death in NCI-H292 cancer cellsCeleste Caruso Bavisotto, Dragana Nikolic, Antonella Marino Gammazza, et al.
Bioorganic & Medicinal Chemistry|December 4, 2014
New potent antibacterials against Gram-positive multiresistant pathogens: effects of side chain modification and chirality in linezolid-like 1,2,4-oxadiazolesCosimo G Fortuna, Roberto Berardozzi, Carmela Bonaccorso, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 8, 2024
TRF2 as novel marker of tumor response to taxane-based therapy: from mechanistic insight to clinical implicationSara Iachettini, Irene Terrenato, Manuela Porru, et al.
Minerva Endocrinology|December 11, 2024
Neuroendocrine neoplasms of the breast: a multicenter retrospective Italian studyRoberto Baldelli, Marta Franco, Valerio Renzelli, et al.
Journal of Personalized Medicine|August 25, 2023
An Innovative Scoring System to Select the Optimal Surgery in Breast Cancer after Neoadjuvant ChemotherapyAntonio Franco, Alba Di Leone, Marco Conti, et al.
Pageof 46